SMAR - Healthy outlook ahead

22 Mar 2021

SMAR is not yet profitable due to their SG&A as well as R&D related costs - proper of the growth stage the company is currently navigating. Nevertheless, they have healthy financials (gross margin, strong cash position, low debt levels). Overall, the company posted a 69% EPS QoQ increase and a 40% sales increase in the last quarter. In fact, SMAR has an average growth rate of +50% on sales over the last 3y. Current estimates point to a ~40% increase in sales for the FY'2021 (sales growth expectancy remains very high for the years ahead). I see this as a good entry opportunity following the recent sell-off, as there seem to exist some important support levels below.

6 May 2021

İşlem kapandı: durdurma seviyesi

Trade closed as the stop was reached. Keeping an eye on it as the company should achieve profitability soon and invert the trend